AI Agentic Workflow for Multi-Parameter Optimization (MPO) in Lead Series

Manual lead optimization involves reconciling conflicting priorities from chemistry, biology, DMPK, and safety teams, often stalling progress for weeks. This workflow replaces subjective debate with an objective, auditable scoring agent that applies a pre-defined, portfolio-aligned MPO algorithm. It ingests all experimental and predicted data, visualizes candidates in multi-dimensional property space, and outputs a ranked list with clear rationale, compressing decision cycles from months to days.

Advancing molecules that excel in potency but fail in developability is a primary cause of costly Phase I/II failures. The automated MPO workflow enforces a balanced target product profile (TPP) from the start, integrating predictive models for ADMET, physicochemical properties, and synthetic feasibility into a single composite score. By systematically filtering out molecules with critical liabilities before synthesis, teams improve the probability of technical success, protecting millions in downstream development costs.

Medicinal chemists waste significant time manually triaging hundreds of potential analogs. This workflow automates the generation of focused, synthesis-ready candidate lists. Agents use the MPO score to prioritize analogs, cross-reference available building blocks, and propose retrosynthetic routes. The output is a directed list of 10-20 top-ranked compounds with associated synthesis plans, enabling chemists to focus their expertise on execution rather than selection, dramatically increasing the value-added output per chemist FTE.

Portfolio governance and regulatory inquiries require a clear rationale for why one candidate was selected over another. A manual process leaves this rationale fragmented across emails and slide decks. The custom MPO workflow logs all input data, model versions, weighting schemes, and scoring calculations, generating an immutable audit trail for every ranking. This built-in governance is critical for internal portfolio reviews, partner collaborations, and regulatory discussions, reducing compliance risk and stakeholder friction.

Portfolio managers struggle to objectively compare progress across multiple lead optimization programs competing for limited synthetic and assay resources. This workflow enables apples-to-apples comparison by applying a consistent, portfolio-level MPO framework to all series. It generates normalized scores and progress dashboards, allowing leadership to dynamically reallocate resources to the series with the highest overall probability of success, improving overall R&D ROI and portfolio yield.

Lead optimization knowledge is often tribal, residing in key scientists' heads. When team members change, critical context is lost. The automated MPO workflow codifies the project's strategic goals—potency vs. selectivity vs. PK trade-offs—into a living, executable algorithm. This serves as a persistent source of truth for the series strategy, drastically shortening the onboarding time for new team members and preserving institutional knowledge, ensuring project continuity and momentum.

The core orchestration agent that applies customizable MPO algorithms (e.g., weighted sum, Pareto ranking) to balance potency, selectivity, ADMET, and physicochemical scores. It ingests structured data from other agents, visualizes candidates in multi-dimensional property space, and generates a unified, ranked list based on the target product profile. This replaces manual spreadsheet analysis and subjective team debates with a reproducible, auditable scoring process.

A specialized agent that queries a suite of validated in silico models to predict critical ADMET properties (e.g., solubility, permeability, hERG inhibition, metabolic stability). It flags molecules with severe liabilities early, preventing the advancement of high-risk compounds. This agent integrates with commercial platforms and internal QSAR models, ensuring predictions are standardized and traceable across the project lifecycle.

This agent bridges digital design and physical synthesis. It uses retrosynthesis AI to propose feasible synthetic pathways for top-ranked candidates, scores them for complexity and cost, and checks reagent availability against internal inventory or vendor catalogs. By providing a synthesizability score and draft routes, it grounds the MPO process in practical chemistry, preventing the selection of unrealistic targets and accelerating handoff to medchem teams.

Not an agent, but a critical component: a dynamic dashboard that renders the multi-dimensional property space (e.g., parallel coordinates, radar charts) for the lead series. It allows project teams to interactively adjust MPO weightings, visualize trade-offs, and drill into agent rationale for specific scores. This component integrates with ELNs (e.g., Benchling) and provides an audit trail for candidate selection meetings, supporting defensible governance.

The underlying workflow engine (e.g., LangGraph, Prefect) that sequences agent tasks, manages data flow between systems (e.g., compound registry, ELN, HPC clusters), and enforces approval gates. It handles exception routing for molecules that fail critical filters and logs all agent decisions for model performance monitoring and regulatory auditability. This layer ensures the workflow is reproducible, scalable, and integrates with existing R&D IT infrastructure.

The connective tissue that aggregates structured data from disparate sources: assay databases for potency/selectivity, computational chemistry outputs for docking scores, and internal registries for compound structures. This pipeline cleans, standardizes, and feeds data to the specialized agents. A poorly implemented pipeline is the primary point of failure; a robust one using event-driven architecture ensures agents operate on a single source of truth, eliminating manual data wrangling.

This group owns the Target Product Profile (TPP) and defines the scoring weights and trade-off tolerances for potency, selectivity, ADMET, and physicochemical properties. Their involvement is critical for validating the MPO algorithm's outputs and ensuring the workflow's recommendations align with project strategy and synthetic feasibility. Without their continuous input, the system risks optimizing for computationally convenient but chemically irrelevant metrics.

This team is responsible for implementing and validating the MPO scoring agent, integrating predictive models (e.g., ADMET, QSAR), and ensuring the quality of input data from virtual screening and assays. They architect the data pipelines from sources like internal ELNs (e.g., Benchling) and public databases (e.g., ChEMBL) into a unified compound registry that feeds the optimization engine.

This group provisions the scalable compute infrastructure (e.g., AWS Batch, Kubernetes) for high-throughput scoring and visualization. They implement the orchestration layer (using frameworks like LangGraph or Prefect), manage the CI/CD pipeline for the MPO agents, and establish monitoring for model performance and data drift to ensure the workflow's reliability and auditability.

As the primary consumers of the workflow's output, these teams execute on the recommended compound lists. Their feedback on synthesizability scores and route plans is essential for grounding the digital workflow in practical reality. Early alignment ensures the MPO system incorporates realistic cost, timeline, and reagent availability constraints from the start, preventing the recommendation of impractical candidates.

This stakeholder group requires the workflow to produce a defensible, auditable decision trail. They mandate the inclusion of approval gates, version control for scoring algorithms, and clear visualization of the trade-off space to support objective portfolio reviews. Their buy-in is necessary to shift lead selection from subjective debate to a data-driven, reproducible process.

Successful deployment follows a phased approach: 1) Pilot on a single lead series with a defined TPP, 2) Integrate with the compound registry and visualization dashboard, and 3) Scale to multiple projects with customized MPO templates. Each phase requires joint review sessions with all stakeholders to calibrate the system, handle exceptions, and refine the human-in-the-loop review process before full automation.